A whole genome bioinformatic approach to determine potential latent phase specific targets in Mycobacterium tuberculosis

Tuberculosis
Lucas A DefelipeMarcelo A Marti

Abstract

Current Tuberculosis treatment is long and expensive, faces the increasing burden of MDR/XDR strains and lack of effective treatment against latent form, resulting in an urgent need of new anti-TB drugs. Key to TB biology is its capacity to fight the host's RNOS mediated attack. RNOS are known to display a concentration dependent mycobactericidal activity, which leads to the following hypothesis "if we know which proteins are targeted by RNOS and kill TB, we we might be able to inhibit them with drugs resulting in a synergistic bactericidal effect". Based on this idea, we performed an Mtb metabolic network whole proteome analysis of potential RNOS sensitive and relevant targets which includes target druggability and essentiality criteria. Our results, available at http://tuberq.proteinq.com.ar yield new potential TB targets, like I3PS, while also providing and updated view of previous proposals becoming an important tool for researchers looking for new ways of killing TB.

References

May 15, 1973·Journal of Molecular Biology·S T Rao, M G Rossmann
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·A E BelangerJ M Inamine
Jan 1, 1997·Annual Review of Immunology·J MacMickingC Nathan
Jun 21, 2001·Proceedings of the National Academy of Sciences of the United States of America·D R ShermanG K Schoolnik
Sep 7, 2001·Annual Review of Microbiology·L G Wayne, C D Sohaskey
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kaman ChanLalita Ramakrishnan
Jul 26, 2002·Nature·Guri GiaeverMark Johnston
Aug 10, 2002·Bioinformatics·Peter D KarpPedro Romero
Sep 5, 2002·Nature Reviews. Drug Discovery·Andrew L Hopkins, Colin R Groom
Nov 7, 2002·Archives of Microbiology·Gerald L Newton, Robert C Fahey
Mar 27, 2003·Molecular Microbiology·Christopher M SassettiEric J Rubin
Sep 4, 2003·The Journal of Experimental Medicine·Dirk SchnappingerGary K Schoolnik
Sep 4, 2003·The Journal of Experimental Medicine·Martin I VoskuilGary K Schoolnik
Oct 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Christopher M Sassetti, Eric J Rubin
Dec 19, 2003·Nucleic Acids Research·Alex BatemanSean R Eddy
Feb 7, 2004·Molecular Microbiology·Farahnaz MovahedzadehNeil G Stoker
Mar 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Rafael Radi
Apr 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Adel M TalaatStephen Albert Johnston
Jun 23, 2004·Tuberculosis·D G Niranjala MuttucumaruTanya Parish
Sep 9, 2004·The Journal of Experimental Medicine·Petros C KarakousisWilliam R Bishai
Dec 14, 2004·The Biochemical Journal·Yvonne Groemping, Katrin Rittinger
Jan 1, 2005·Proceedings of the National Academy of Sciences of the United States of America·Kyu Y RheeCarl F Nathan
Feb 3, 2005·Nature Reviews. Molecular Cell Biology·Douglas T HessJonathan S Stamler
Jun 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jyothi RengarajanEric J Rubin
Jan 10, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Shanqin XuRichard A Cohen
Jun 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Qingjun MaMatthias Wilmanns
Jun 23, 2006·PLoS Computational Biology·Samiul HasanMark Schreiber
Oct 21, 2006·Microbiology and Immunology·Gabriella M ScandurraJames A Triccas
May 15, 2007·Nature Chemical Biology·Anil KoulKoen Andries

❮ Previous
Next ❯

Citations

Nov 7, 2017·Nucleic Acids Research·Ezequiel J SosaDarío Fernández Do Porto
Jul 19, 2018·Scientific Reports·Pablo Ivan Pereira RamosMarisa F Nicolás
Aug 14, 2020·Memórias do Instituto Oswaldo Cruz·Mariella Farfán-LópezDarío A Fernández Do Porto
Jan 1, 2021·Frontiers in Chemistry·Ushashi BanerjeeNagasuma Chandra
Dec 10, 2020·Computational and Structural Biotechnology Journal·Tanushree TunstallNicholas Furnham
Jun 29, 2021·Frontiers in Pharmacology·Federico SerralDarío Fernández Do Porto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.